Assessing trial representativeness using Serious Adverse Events: An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data

Peter Hanlon; Elaine Butterly; Anoop S. Shah; Laurie Hannigan; Sarah H. Wild; Bruce Guthrie; Frances S Mair; Sofia Dias; Nicky J. Welton; David A. McAllister

doi:https://doi.org/10.1186/s12916-022-02594-9

Assessing trial representativeness using Serious Adverse Events: An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data

Peter Hanlon^*, Elaine Butterly, Anoop S. Shah, Laurie Hannigan, Sarah H. Wild, Bruce Guthrie, Frances S Mair, Sofia Dias, Nicky J. Welton, David A. McAllister

^*Corresponding author for this work

Centre for Reviews and Dissemination

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	410
Number of pages	15
Journal	BMC Medicine
Volume	20
DOIs	https://doi.org/10.1186/s12916-022-02594-9
Publication status	Published - 28 Oct 2022

Bibliographical note

Access to Document

https://doi.org/10.1186/s12916-022-02594-9Licence: CC BY

s12916-022-02594-9
© The Author(s) 2022
Final published version, 2.11 MBLicence: CC BY

Cite this

Hanlon, P., Butterly, E., Shah, A. S., Hannigan, L., Wild, S. H., Guthrie, B., Mair, F. S., Dias, S., Welton, N. J., & McAllister, D. A. (2022). Assessing trial representativeness using Serious Adverse Events: An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data. BMC Medicine, 20, Article 410. https://doi.org/10.1186/s12916-022-02594-9

@article{e1e1df1de4d4408c81d799ac5e7a048b,

title = "Assessing trial representativeness using Serious Adverse Events: An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data",

author = "Peter Hanlon and Elaine Butterly and Shah, {Anoop S.} and Laurie Hannigan and Wild, {Sarah H.} and Bruce Guthrie and Mair, {Frances S} and Sofia Dias and Welton, {Nicky J.} and McAllister, {David A.}",

note = "{\textcopyright} The Author(s) 2022",

year = "2022",

month = oct,

day = "28",

doi = "https://doi.org/10.1186/s12916-022-02594-9",

language = "English",

volume = "20",

journal = "BMC Medicine",

issn = "1741-7015",

publisher = "BioMed Central",

}

Hanlon, P, Butterly, E, Shah, AS, Hannigan, L, Wild, SH, Guthrie, B, Mair, FS, Dias, S, Welton, NJ & McAllister, DA 2022, 'Assessing trial representativeness using Serious Adverse Events: An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data', BMC Medicine, vol. 20, 410. https://doi.org/10.1186/s12916-022-02594-9

TY - JOUR

T1 - Assessing trial representativeness using Serious Adverse Events

T2 - An observational analysis using aggregate and individual-level data from clinical trials and routine healthcare data

AU - Hanlon, Peter

AU - Butterly, Elaine

AU - Shah, Anoop S.

AU - Hannigan, Laurie

AU - Wild, Sarah H.

AU - Guthrie, Bruce

AU - Mair, Frances S

AU - Dias, Sofia

AU - Welton, Nicky J.

AU - McAllister, David A.

PY - 2022/10/28

Y1 - 2022/10/28

U2 - https://doi.org/10.1186/s12916-022-02594-9

DO - https://doi.org/10.1186/s12916-022-02594-9

M3 - Article

SN - 1741-7015

VL - 20

JO - BMC Medicine

JF - BMC Medicine

M1 - 410

ER -